Docusign (NASDAQ:DOCU) Price Target Raised to $90.00

Docusign (NASDAQ:DOCU) had its target price hoisted by Robert W. Baird from $85.00 to $90.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other equities research analysts also recently weighed in on DOCU. UBS Group lowered their target price on shares of Docusign from $85.00 to $80.00 and set a “neutral” rating on the stock in a research note on Friday, June 6th. Wells Fargo & Company raised shares of Docusign from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $67.00 to $80.00 in a report on Friday, June 13th. JPMorgan Chase & Co. lifted their price objective on shares of Docusign from $77.00 to $80.00 and gave the stock a “neutral” rating in a report on Friday. Royal Bank Of Canada upped their target price on shares of Docusign from $90.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Friday. Finally, Bank of America raised their price target on Docusign from $85.00 to $102.00 and gave the company a “neutral” rating in a research report on Friday. Four equities research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Docusign presently has a consensus rating of “Hold” and a consensus target price of $93.14.

Docusign Stock Performance

NASDAQ:DOCU opened at $79.86 on Friday. Docusign has a 52-week low of $54.31 and a 52-week high of $107.86. The stock has a fifty day moving average of $75.53 and a 200 day moving average of $79.30. The firm has a market capitalization of $16.14 billion, a price-to-earnings ratio of 60.05, a P/E/G ratio of 29.81 and a beta of 1.02.

Docusign (NASDAQ:DOCU) last announced its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities analysts forecast that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign declared that its board has approved a stock buyback plan on Thursday, June 5th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.6% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board believes its shares are undervalued.

Insider Buying and Selling at Docusign

In other Docusign news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58. Following the completion of the sale, the director directly owned 8,805 shares in the company, valued at $654,827.85. This represents a 5.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the firm’s stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total value of $1,132,696.40. Following the transaction, the chief financial officer directly owned 110,723 shares in the company, valued at $8,282,080.40. This trade represents a 12.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 78,552 shares of company stock valued at $5,983,631. Company insiders own 1.66% of the company’s stock.

Institutional Trading of Docusign

Several hedge funds and other institutional investors have recently bought and sold shares of DOCU. New Age Alpha Advisors LLC grew its holdings in shares of Docusign by 738.2% in the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company’s stock worth $3,353,000 after purchasing an additional 36,273 shares during the last quarter. Pinpoint Asset Management Ltd grew its holdings in Docusign by 54.3% in the 1st quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company’s stock worth $4,639,000 after acquiring an additional 20,043 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new position in shares of Docusign in the first quarter valued at about $618,000. Gilman Hill Asset Management LLC raised its stake in shares of Docusign by 4.9% during the first quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company’s stock valued at $6,864,000 after acquiring an additional 3,904 shares during the last quarter. Finally, Blair William & Co. IL boosted its holdings in shares of Docusign by 1.7% during the first quarter. Blair William & Co. IL now owns 387,542 shares of the company’s stock worth $31,546,000 after purchasing an additional 6,460 shares during the period. Institutional investors own 77.64% of the company’s stock.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.